Home  /  Resource Library  /  Radiation Therapy As a Bridging Strategy for Refractory Diffuse Large B Cell Lymphoma Patients Awaiting CAR T Manufacturing of Axicabtagene Ciloleucel

Radiation Therapy As a Bridging Strategy for Refractory Diffuse Large B Cell Lymphoma Patients Awaiting CAR T Manufacturing of Axicabtagene Ciloleucel

Study investigated the effectiveness of radiation therapy as an option for bridging DLBCL patients who were waiting for CAR T therapy Axicabtagene Ciloleucel.